Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1406Neoplasms 1131Prostatic Neoplasms 746Lung Neoplasms 622Colorectal Neoplasms 598Carcinoma, Non-Small-Cell Lung 571Carcinoma, Hepatocellular 416Pancreatic Neoplasms 401Leukemia, Myeloid, Acute 398Stomach Neoplasms 356Multiple Myeloma 327Brain Neoplasms 313Ovarian Neoplasms 309Head and Neck Neoplasms 292Neoplasm Metastasis 277Precursor Cell Lymphoblastic Leukemia-Lymphoma 261Rectal Neoplasms 255Uterine Cervical Neoplasms 248Recurrence 248Melanoma 243Esophageal Neoplasms 237Glioblastoma 232Squamous Cell Carcinoma of Head and Neck 230Lymphoma 214Sarcoma 209Urinary Bladder Neoplasms 194Colonic Neoplasms 192Glioma 191Triple Negative Breast Neoplasms 190Hematologic Neoplasms 183

Interventions

Pharmaceutical Preparations 1Irinotecan 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × OTHER × BRAF V600 Colorectal Cancer × Clear all
NCT07150247 2025-09-26

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 2 Recruiting
20 enrolled
Gastrointestinal

BRAF V600 Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡